Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation
Clinical Scorecard: Assessment of Two Risk Scores for Syncope and Their Comparison to Physician Risk Evaluations
At a Glance
Category Detail
Condition Syncope and presyncope Key Mechanisms Transient loss of consciousness due to inadequate cerebral blood flow Target Population Adults aged 40 years or older presenting with syncope or presyncope Care Setting Emergency Department (ED)
Key Highlights
Syncope accounts for 2-3% of all ED visits. 5-10% of patients without serious diagnoses may experience adverse outcomes within 30 days. The Canadian Syncope Risk Score (CSRS) and FAINT score are tools for risk stratification. Neither CSRS nor FAINT score has been prospectively validated in the US. Unstructured physician estimates of risk are compared to these scoring tools. Guideline-Based Recommendations
Diagnosis
Utilize CSRS and FAINT score for risk stratification. Management
Consider hospitalization for monitoring based on risk scores. Monitoring & Follow-up
Assess for serious adverse outcomes within 30 days. Risks
5-10% risk of serious adverse outcomes in patients without obvious serious diagnoses. Patient & Prescribing Data
Adults aged 40 years or older with syncope or presyncope.
Risk scores can guide clinical management and reduce unnecessary hospitalizations.
Clinical Best Practices
Incorporate objective risk scores in ED evaluations. Ensure thorough clinical assessment and documentation. Follow TRIPOD and STROBE guidelines for reporting. Related Resources & Content
